IP Library Granted Patent US 11,510,994
Granted Patent B2
US 11,510,994 · App. 17/554,668 · Granted Nov 29, 2022

Linkers for improving the stability of bioconjugates and the selectivity of payload release

Inventors: Matthew Giese (Columbus, OH); Paul D. Davis (Dublin, OH)
Assignee: EqIP, LLC
A61K47/6889A61K47/542A61K47/545A61K47/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,510,994
App. No.
17/554,668
Granted
Nov 29, 2022
Kind
B2
Abstract

Disclosed herein are linker architectures for conjugates that do not rely on the SAR of the cleavable trigger or the large steric bulk of a closely positioned antibody to alter payload release. These linkers are expected to reduce off-target payload release facilitated by extracellular cathepsins, and may also be applicable to conjugates of antibody fragments that lack the steric protection from a full antibody. In addition, the linkers disclosed herein are expected to provide more selective intracellular payload release. Thus, these linkers can function synergistically with the targeting vector to confer differential payload release rates in vivo that improve the selectivity of intracellular payload release and reduce off target toxicity.

Claims (25)

1. A compound of Formula (Ib), having the structure:

or a pharmaceutically acceptable salt, solvate, or isomer thereof,

wherein:

FG 1 is a reactive functional group capable of conjugation to a targeting vector;

FG 2 is a reactive functional group capable of conjugation to a payload;

t is an integer from 0 to 4;

each x is independently an integer from 4 to 48;

y is 2 or 3; and

D 1 and D2 are each independently an alkylene optionally comprising one or more heteroatoms selected from N and O, and optionally substituted with one or more oxo groups,

wherein:

D, the number of atoms in a linear chain between FG 1 and FG 2 is from 10 to 30 atoms; and D′, the number of atoms in a linear chain between

and FG 2 is less than or equal to 22 atoms.

2. The compound of claim 1 , wherein D 1 is selected from the group consisting of:

wherein z is 2 or 4.

3. The compound of claim 1 , wherein D 2 is

and v is 0 or 1 and w is 1 to 5.

4. The compound of claim 1 , wherein FG 1 is

5. The compound of claim 1 , wherein FG 2 is

6. The compound of claim 1 , wherein x is 8 and y is 3.

7. The compound of claim 1 , wherein x is 24 and y is 3.

8. The compound of claim 1 , wherein x is 8 or 24.

9. The compound of claim 1 , wherein t is 0 or 1.

10. The compound of claim 1 , having the structure:

wherein R 1 is —OH,

and x is 8 or 24.

Assignments (2)
SECURITY INTEREST Recorded Aug 10, 2023
From: EQIP, LLC
To: AUDAX PRIVATE DEBT LLC, AS AGENT
Reel/Frame 064554/0194 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2022
From: GIESE, MATTHEW; DAVIS, PAUL D
To: EQIP, LLC
Reel/Frame 060631/0059 →